Skip to main content
. Author manuscript; available in PMC: 2016 Apr 15.
Published in final edited form as: Clin Cancer Res. 2015 Jun 17;21(20):4586–4596. doi: 10.1158/1078-0432.CCR-15-0584

Table 3.

Details of mutations identified in tumor tissue and in plasma at Cycle 1 Day 1 on the PGM platform. ND: not detected.

TUMOR PLASMA
PGM PGM
Tumor Type Gene Mutation % Coverage Gene Mutation % Coverage
#1 Colorectal cancer KRAS G12V 46 820 KRAS G12V 19 630
TP53 R248Q 31 991 TP53 R248Q 9 1997
TP53 R158fs*11 50 825 TP53 R158fs*11 16 1008
APC A1492fs*15 44 989 APC A1492fs*15 15 746
#2 Breast cancer TP53 H193Y 37 1008 TP53 H193Y ND 3187
#3 Ovarian cancer TP53 S96fs*53 87 368 TP53 S96fs*53 ND 879
#4 Ovarian cancer KRAS G12D 20 1555 KRAS G12D ND 473
PIK3CA E545K 23 1717 PIK3CA E545K ND 678
#5 Colorectal cancer FBXW7 S582L 31 1744 FBXW7 S582L 46 1998
PIK3CA E542K 31 1010 PIK3CA E542K 58 1994
TP53 R282W 31 1447 TP53 R282W 43 904
#6 Breast cancer KRAS G12S 43 533 KRAS G12S 3 1519
PIK3CA N1044S 39 516 PIK3CA N1044S 9.1 986
#7 Colorectal cancer PIK3CA Q546K 26 754 PIK3CA Q546K 31 6509
TP53 Y234* 28 640 TP53 Y234* 57 8395
KRAS G12C 19 772 KRAS G12C 36 1723
APC E1374* 30 712 APC E1374* 33 2116
#8 Ovarian cancer PIK3CA E545K 16 6676 PIK3CA E545K ND 2333
KRAS G12D 29 6801 KRAS G12D ND 522
#9 Ovarian cancer TP53 Y220C ND 700 TP53 Y220C 5.4 1162
#10 Ovarian cancer PIK3CA E542K 40 7169 PIK3CA E542K ND 3895
#11 Ovarian cancer TP53 R175H 67 255 TP53 R175H ND 858
#12 Breast cancer TP53 H179R 90 353 TP53 H179R 13.6 655
#13 Breast cancer TP53 R175H 23 175 TP53 R175H 7.6 1799
TP53 D281H 17 281 TP53 D281H 2 1756
#14 Bladder cancer CDKN2A H83Y 76 212 CDKN2A H83Y 4 1626
#15 Colorectal cancer NRAS G12S 37 2662 NRAS G12S 51 1088
#16 Colorectal cancer KRAS G12D 25 907 KRAS G12D 7.9 665
PIK3CA Q546R 24 1130 PIK3CA Q546R 13 1785
TP53 G244D 33 930 TP53 G244D 6,7 2100
#17 Breast cancer TP53 R342fs*2 30 238 TP53 R342fs*2 23 1214
#18 Penile cancer PIK3CA E545K 9,1 1483 PIK3CA E545K 4.9 1763
#19 Ovarian cancer TP53 A138P 64 446 TP53 A138P ND 2413
PTEN EXON3-4S 26 899 PTEN EXON3-4S ND 1237
#20 Lung adenocarcinoma KRAS G12C 57 2084 KRAS G12C ND 849
#21 Endometrial cancer TP53 P190L 89 1213 TP53 P190L <1% 7044
#22 Ovarian cancer PTEN L70fs*4 11,5 1795 PTEN L70fs*4 ND 546
#23 Colorectal cancer KRAS G12V 40 1705 KRAS G12V 4.4 1365
TP53 R175H 58 151 TP53 R175H ND 686
#24 Glioblastoma TP53 K132N 65 689 TP53 K132N ND 37094
PIK3CA E542K 33 954 PIK3CA E542K ND 33631
#25 Colorectal cancer KRAS G12V 43 2380 KRAS G12V ND 1119
PTEN V317fs* 28 1938 PTEN V317fs* ND 1300
TP53 R273C 65 2231 TP53 R273C ND 373
#26 Colorectal cancer KRAS Q61H 75 5376 KRAS Q61H 51 2960
APC S1501A 57 937 APC S1501A 28 1915
APC S1495fs*14 41 2213 APC S1495fs*14 26 1790
SMAD4 G386R 49 1171 SMAD4 G386R 26 280
ATM R337C 42 1179 ATM R337C 18 781
#27 Colorectal cancer KRAS G12V 40 1897 KRAS G12V ND 4627
TP53 P151S 45 247 TP53 P151S ND 2776
#28 Breast cancer PIK3CA E545K 16 1183 PIK3CA E545K ND 2327
PTEN L325R 22 851 PTEN L325R ND 1661
PTEN E235fs*2 11 922 PTEN E235fs*2 ND 1495
TP53 N210fs*54 39 524 TP53 N210fs*54 ND 3450
#29 Breast cancer TP53 E171* 70 240 TP53 E171* 6.5 740
#30 Melanoma BRAF V600E 58 1395 BRAF V600E ND 2238
#31 Colorectal cancer KRAS G12D 8 1845 KRAS G12D 3.4 567
APC R1114* 9 3491 APC R1114* ND 685
#32 Glioblastoma FBXW7 R484K 6 439 FBXW7 R484K ND 5600
#33 Bladder cancer PIK3CA E545K 28 3253 PIK3CA E545K 8.5 778
TP53 E180K 12 899 TP53 E180K 6.1 836
TP53 R175H 19 899 TP53 R175H 8 840
#34 Colorectal cancer KRAS G12D 33 769 KRAS G12D 4.5 866
TP53 R175H 29 879 TP53 R175H 16 1119
#35 Lung adenocarcinoma TP53 G154V 16 386 TP53 G154V 4.6 1080
#36 Colorectal cancer PIK3CA H1074R 56 819 PIK3CA H1074R 40 1503
TP53 R175H 57 205 TP53 R175H 60 1287
#37 Renal cell cancer TP53 E285K 51 226 TP53 E285K 16.3 632
#38 Bladder cancer PIK3CA E545K 56 2266 PIK3CA E545K 9.4 1024
TP53 D281N 44 950 TP53 D281N 3.2 724
TP53 P278L 44 951 TP53 P278L ND 732
#39 Ovarian cancer CTNNB1 S33C 24 678 CTNNB1 S33C ND 1425
PIK3CA N345K 41 946 PIK3CA N345K 7.8 4139